Steve Yang, Ph.DExecutive Vice President, Chief Business Officer
Formerly Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca, previous roles including Vice President and Head of R&D Asia at Pfizer. Ph.D in Pharmaceutical Chemistry from the University of California, San Francisco.
Xuehai Tan, Ph.DSenior Vice President, Founder, CEO & President of HD Biosciences
A founder of HD Biosciences and over 30 years’ experience in Drug Discovery. Ph.D in Biochemistry and Molecular Biology from Medical University of Ohio, post-doc and assistant professor at University of Washington. Formerly worked in Johnson & Johnson, Aurora Biosciences, and founded HD Biosciences in 2002.
Jingchao Dong, Ph.DSenior Vice President of Chemistry Service Unit
Over 18 years' experience in organic chemistry and medicinal chemistry. Ph.D in medicinal chemistry from Peking University.
Tao Guo, Ph.DVice President of International Discovery Service Unit
Over 20 years’ experience in organic/medicinal chemistry, formerly Director of Chemistry at Pharmacopeia. B.S. in Chemistry from Peking University, Ph.D in Organic Chemistry from Columbia University, and postdoctoral fellow in Bioorganic Chemistry at UC Berkeley.
Rujian Ma, Ph.DVice President of Chemistry Technology Unit
Over 17 years' experience in organic synthesis and in training new fellow scientists. Ph.D in Pharmaceutical Sciences from the Faculty of Pharmaceutical Sciences, the University of Tokushima.
Henry Lu, Ph.DVice President, Head of Biology
Over 20 years’ experience in biological research and pharmaceutical industry. Formerly Adjunct Associate Professor at the University of California San Francisco, Senior Director of Infectious Diseases at Rigel Pharmaceuticals Inc. B.S. from Fudan University, Ph.D from the Shanghai Institute of Biochemistry, Academia Sinica.
Qunsheng Ji, Ph.DVice President, Head of Oncology and Immunology Unit
Over 15 years of industry experience in drug discovery and translational science especially in oncology and recently renal diseases. Ph.D from Chinese Academy of Medical Science/ Peking Union Medical College, jointed with Vanderbilt University USA, Medical degree from First Military Medical University in Guangzhou.
Declan Ryan, Ph.DVice President, US Business Development
Over 20 years' experience in R&D in both research and business development roles at 3-Dimensional Pharmaceuticals, Novartis, Johnson & Johnson, AMRI and Shanghai ChemPartner. Ph.D from University of Lausanne, Switzerland and Post-doc studies at Yale University and University of Pittsburgh, USA.
Dave Madge, Ph.DVice President, Research Service Division
Over 20 years’ experience working within academia, biotech and CROs. Former VP Research at Xention, founder of NCE Discovery (now Domainex) and a member of the integrated biomedical research group at University College London. Dave started his career at the Wellcome Foundation and received his Ph.D in Chemistry from Imperial College, London.
Baoning Su, Ph.DVice President of Core Analytical Services (CAS) Unit
Over 20 years working experience in the areas of natural products and pharmaceutical analyses, formerly Senior Research Investigator at Bristol-Myers Squibb. Ph.D in Organic Chemistry from Lanzhou University.
Ismail Moarefi, Ph.DExecutive Director, Science & New Technologies, Crelux
A founder of Crelux and CSO for 13 years, Ismail is responsible for science and new technologies. His team of experts support a global network of customers offering structural biology and biophysical assays for hit finding and lead optimization. Before Crelux, Ismail successfully co-founded a series of start-up companies.